Corneal crosslinking with riboflavin and UVA for the treatment of keratoconus.

摘要

The article by Caporossi et al. about corneal cross-linking with riboflavin and ultraviolet-A (UVA) for the treatment of keratoconus in combination with the findings of other recent studies offers the scientific community an innovative and probably promising solution for this ectatic dystrophy of the cornea. Because the technique is extremely new and currently under study, we believe that future authors of similar articles should be very careful with the experimental design and the interpretation of findings.